A New Molecular Marker For Prostate Cancer
Researchers discovered a new molecular marker, p27(Kip1), that can predict prostate cancer tumor progression and guide treatment decisions. Low levels of the protein are associated with increased disease recurrence and mortality.
SourceUniversity of Southern California·JournalJNCI Journal of the National Cancer Institute·DateJun 16, 1998